著者検索結果

1

FoxO Transcription Factors and Stem Cell Homeostasis: Insights from the Hematopoietic System 著者: Zuzana Tóthová, D. Gary Gilliland

出版事項 2007

全文の入手全文の入手
Revisão

お気に入りに追加

保存先:
2

Focus on acute leukemias 著者: D. Gary Gilliland, Martin S. Tallman

出版事項 2002

全文の入手全文の入手
Revisão

お気に入りに追加

保存先:
3

Oncogenes in Myeloproliferative Disorders 著者: Ayalew Tefferi, D. Gary Gilliland

出版事項 2007

全文の入手
Revisão

お気に入りに追加

保存先:
4

G<scp>ENETICS OF</scp> M<scp>YELOID</scp> L<scp>EUKEMIAS</scp> 著者: Louise Kelly, D. Gary Gilliland

出版事項 2002

全文の入手
Revisão

お気に入りに追加

保存先:
5

Myeloproliferative disorders 著者: Ross L. Levine, D. Gary Gilliland

出版事項 2008

全文の入手全文の入手
Revisão

お気に入りに追加

保存先:
6

The leukemic stem cell niche: current concepts and therapeutic opportunities 著者: Steven Lane, David T. Scadden, D. Gary Gilliland

出版事項 2009

全文の入手全文の入手
Revisão

お気に入りに追加

保存先:
7

Summing up cancer stem cells 著者: Brian J.P. Huntly, D. Gary Gilliland

出版事項 2005

全文の入手全文の入手
Carta

お気に入りに追加

保存先:
8

Drug therapy for acute myeloid leukemia 著者: Martin S. Tallman, D. Gary Gilliland, Jacob M. Rowe

出版事項 2005

全文の入手全文の入手
Revisão

お気に入りに追加

保存先:
9

The Molecular Basis of Leukemia 著者: D. Gary Gilliland, Craig T. Jordan, Carolyn A. Felix

出版事項 2004

全文の入手
Revisão

お気に入りに追加

保存先:
10

INTERLEUKIN-1 IS A CRITICAL EFFECTOR MOLECULE DURING CYTOKINE DYSREGULATION IN GRAFT VERSUS HOST DISEASE TO MINOR HISTOCOMPATIBILITY ANTIGENS1 著者: Sunil Abhyankar, D. Gary Gilliland, James L.M. Ferrara

出版事項 1993

全文の入手
Artigo

お気に入りに追加

保存先:
11

ARG tyrosine kinase activity is inhibited by STI571 著者: Keiko Okuda, Ellen Weisberg, D. Gary Gilliland, James D. Griffin

出版事項 2001

全文の入手全文の入手
Artigo

お気に入りに追加

保存先:
12

Host genetic variation contributes to phenotypic diversity in myeloproliferative disorders 著者: Animesh Pardanani, Brooke L. Fridley, Terra L. Lasho, D. Gary Gilliland, Ayalew Tefferi

出版事項 2007

全文の入手全文の入手
Artigo

お気に入りに追加

保存先:
13

Socs-1 Inhibits TEL-JAK2-Mediated Transformation of Hematopoietic Cells through Inhibition of JAK2 Kinase Activity and Induction of Proteasome-Mediated Degradation 著者: Julie Frantsve‐Hawley, Juerg Schwaller, David Sternberg, Jeffery L. Kutok, D. Gary Gilliland

出版事項 2001

全文の入手
Artigo

お気に入りに追加

保存先:
14

Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction. 著者: D. Gary Gilliland, K L Blanchard, Jonathan M. Levy, Sean Perrin, H. Franklin Bunn

出版事項 1991

全文の入手
Artigo

お気に入りに追加

保存先:
15

The FIP1L1-PDGFRα fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management 著者: Jason Gotlib, Jan Cools, James Malone, Stanley L. Schrier, D. Gary Gilliland, Steven Coutré

出版事項 2003

全文の入手全文の入手
Revisão

お気に入りに追加

保存先:
16

The TEL/platelet-derived growth factor β receptor (PDGFβR) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGFβR kinase-depe... 著者: Martin Carroll, Michael H. Tomasson, George F. Barker, Todd R. Golub, D. Gary Gilliland

出版事項 1996

全文の入手
Artigo

お気に入りに追加

保存先:
17

FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model 著者: Louise Kelly, Qing Liu, Jeffrey L. Kutok, Ifor R. Williams, Christina Boulton, D. Gary Gilliland

出版事項 2002

全文の入手全文の入手
Artigo

お気に入りに追加

保存先:
18

Expression of Jak2V617F causes a polycythemia vera–like disease with associated myelofibrosis in a murine bone marrow transplant model 著者: Gerlinde Wernig, Thomas Mercher, Rachel Okabe, Ross L. Levine, Benjamin H. Lee, D. Gary Gilliland

出版事項 2006

全文の入手全文の入手
Artigo

お気に入りに追加

保存先:
19

Skewing of X-inactivation ratios in blood cells of aging women is confirmed by independent methodologies 著者: Lambert Busque, Yves Paquette, Sylvie Provost, Denis‐Claude Roy, Ross L. Levine, Luigina Mollica, D. Gary Gilliland

出版事項 2009

全文の入手
Artigo

お気に入りに追加

保存先:
20

Prediction of Resistance to Small Molecule FLT3 Inhibitors 著者: Jan Cools, Nicole Mentens, Pascal Furet, Doriano Fabbro, Jennifer Clark, James D. Griffin, Peter Marynen, D. Gary Gilliland

出版事項 2004

全文の入手
Artigo

お気に入りに追加

保存先:

検索結果 - D. Gary Gilliland

FoxO Transcription Factors and Stem Cell Homeostasis: Insights from the Hematopoietic System 著者: Zuzana Tóthová, D. Gary Gilliland

Focus on acute leukemias 著者: D. Gary Gilliland, Martin S. Tallman

Oncogenes in Myeloproliferative Disorders 著者: Ayalew Tefferi, D. Gary Gilliland

G<scp>ENETICS OF</scp> M<scp>YELOID</scp> L<scp>EUKEMIAS</scp> 著者: Louise Kelly, D. Gary Gilliland

Myeloproliferative disorders 著者: Ross L. Levine, D. Gary Gilliland

The leukemic stem cell niche: current concepts and therapeutic opportunities 著者: Steven Lane, David T. Scadden, D. Gary Gilliland

Summing up cancer stem cells 著者: Brian J.P. Huntly, D. Gary Gilliland

Drug therapy for acute myeloid leukemia 著者: Martin S. Tallman, D. Gary Gilliland, Jacob M. Rowe

The Molecular Basis of Leukemia 著者: D. Gary Gilliland, Craig T. Jordan, Carolyn A. Felix

INTERLEUKIN-1 IS A CRITICAL EFFECTOR MOLECULE DURING CYTOKINE DYSREGULATION IN GRAFT VERSUS HOST DISEASE TO MINOR HISTOCOMPATIBILITY ANTIGENS1 著者: Sunil Abhyankar, D. Gary Gilliland, James L.M. Ferrara

ARG tyrosine kinase activity is inhibited by STI571 著者: Keiko Okuda, Ellen Weisberg, D. Gary Gilliland, James D. Griffin

Host genetic variation contributes to phenotypic diversity in myeloproliferative disorders 著者: Animesh Pardanani, Brooke L. Fridley, Terra L. Lasho, D. Gary Gilliland, Ayalew Tefferi

Socs-1 Inhibits TEL-JAK2-Mediated Transformation of Hematopoietic Cells through Inhibition of JAK2 Kinase Activity and Induction of Proteasome-Mediated Degradation 著者: Julie Frantsve‐Hawley, Juerg Schwaller, David Sternberg, Jeffery L. Kutok, D. Gary Gilliland

Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction. 著者: D. Gary Gilliland, K L Blanchard, Jonathan M. Levy, Sean Perrin, H. Franklin Bunn

The FIP1L1-PDGFRα fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management 著者: Jason Gotlib, Jan Cools, James Malone, Stanley L. Schrier, D. Gary Gilliland, Steven Coutré

The TEL/platelet-derived growth factor β receptor (PDGFβR) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGFβR kinase-depe... 著者: Martin Carroll, Michael H. Tomasson, George F. Barker, Todd R. Golub, D. Gary Gilliland

FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model 著者: Louise Kelly, Qing Liu, Jeffrey L. Kutok, Ifor R. Williams, Christina Boulton, D. Gary Gilliland

Expression of Jak2V617F causes a polycythemia vera–like disease with associated myelofibrosis in a murine bone marrow transplant model 著者: Gerlinde Wernig, Thomas Mercher, Rachel Okabe, Ross L. Levine, Benjamin H. Lee, D. Gary Gilliland

Skewing of X-inactivation ratios in blood cells of aging women is confirmed by independent methodologies 著者: Lambert Busque, Yves Paquette, Sylvie Provost, Denis‐Claude Roy, Ross L. Levine, Luigina Mollica, D. Gary Gilliland

Prediction of Resistance to Small Molecule FLT3 Inhibitors 著者: Jan Cools, Nicole Mentens, Pascal Furet, Doriano Fabbro, Jennifer Clark, James D. Griffin, Peter Marynen, D. Gary Gilliland

検索ツール:

関連主題